Brain Disease News and Research

RSS

Cell therapy slows progression of metachromatic leukodystrophy

In an important discovery, scientists have demonstrated that the progression of a type of genetic brain disease is slowed and symptoms are improved in mice that received cell transplants.

23 Mar 2006

Latest "Mad Cow" case will affect the lifting of bans against American beef

The U.S. Agriculture Department has confirmed that an Alabama cow suspected of having mad cow disease, did have the fatal brain disease.

14 Mar 2006

Valproic acid may help slow the progression of dementia

Researchers have found that a common anticonvulsant drug improved cognitive function and appeared to restore nerve cells in the brains of patients with HIV-related dementia. The results of the Phase I clinical trial are published in the March issue of the scientific journal Neurology.

14 Mar 2006

MS sufferers lobby for return of Tysabri

Despite the deaths of two people among the thousands treated with a promising multiple sclerosis drug, MS patients are trying to persuade the U.S. government to allow the drug back onto the market.

8 Mar 2006

Lifestyle choices help maintain our brain and emotional health

Heart health risk factors and lifestyle choices, such as exercise, learning new things and staying socially connected, are associated with maintaining brain health as we age according to a new report.

24 Feb 2006

New report suggests promising strategies to preserve brain health as people grow older

With the rapid aging of the population, the National Institutes of Health (NIH) is intensifying the search for strategies to preserve brain health as people grow older.

24 Feb 2006

HMRI researcher lights a path to understanding brain diseases

Neurologist Mike Harrington of Pasadena, California's Huntington Medical Research Institutes argues that soon we may be able to detect brain disease before symptoms even begin. The secret is in the cerebrospinal fluid, the clear liquid that cushions our brain and spinal cord.

2 Feb 2006

Concern over decision that new Alzheimer drugs only available for advanced disease

The recommendation by the National Institute of Clinical Evidence (NICE), that Alzheimer's drugs should be used in a minority of people with the degenerative brain disease, has created both rage and disbelief from charities and drug companies alike.

24 Jan 2006

Ataxia gene identified

Researchers at the University of Minnesota Medical School have discovered the gene responsible for a type of ataxia, an incurable degenerative brain disease affecting movement and coordination.

23 Jan 2006

Erectile dysfunction may be sign of coming heart disease

Most wives would say their husbands are notoriously bad about avoiding the doctor’s office. Erectile dysfunction (ED) might be the only problem that prompts some men to go to a physician. According to a new study, it could be their best chance at finding out they have underlying cardiovascular disease.

10 Jan 2006

New pathways linking liver disease to changes in the central nervous system

Liver disease is often associated with "sickness behaviors," such as malaise, listlessness, anorexia, difficulty concentrating, and fatigue. In cholestatic liver diseases (where bile production is impaired) such as primary biliary cirrhosis, fatigue occurs in up to 86 percent of patients.

5 Jan 2006

Withdrawn MS drug works for Crohn's sufferers

Researchers say that a multiple sclerosis drug that was withdrawn from the market for safety reasons, has shown some effectiveness against the painful bowel disorder Crohn's disease.

3 Nov 2005

Protein called CHIP helps untangle protein misfolding in brain disease

Keeping the body and mind healthy depends on keeping cells healthy and functioning. This means that cells need a very robust quality-control system to repair or remove damaged or misshapen proteins. Protein handling is especially important in neurons because damage or death of brain cells causes neurological disease.

1 Nov 2005

Dopamine link to psychiatric and neurological disorders

A gene that regulates dopamine levels in the brain is involved in the development of schizophrenia in children at high risk for the disorder, say researchers at the Stanford University School of Medicine, Lucile Packard Children's Hospital and the University of Geneva.

23 Oct 2005